Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study)

INTRODUCTION: Evidence of a direct comparison between dipeptidyl-peptidase 4 inhibitors (DPP-4is) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) remains lacking, and no clear treatment strategy or rationale has been established using these drugs. This study aimed to compare the overall effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugawara, Masahiro, Fukuda, Masahiro, Sakuma, Ichiro, Wakasa, Yutaka, Funayama, Hideaki, Kondo, Akira, Itabashi, Naoki, Maruyama, Yasuyuki, Kamiyama, Takashi, Utsunomiya, Yasunori, Yamauchi, Akira, Yoshii, Hidenori, Yamada, Hirokazu, Mochizuki, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363101/
https://www.ncbi.nlm.nih.gov/pubmed/37410308
http://dx.doi.org/10.1007/s13300-023-01438-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363101/
https://www.ncbi.nlm.nih.gov/pubmed/37410308
http://dx.doi.org/10.1007/s13300-023-01438-w

Ejemplares similares